BACKGROUND: Microparticles (MPs) have emerged as a surrogate marker of endothelial dysfunction and cardiovascular risk. This study examined the potential of MPs from senescent endothelial cells (ECs) or from patients with acute coronary syndrome (ACS) to promote premature EC aging and thrombogenicity.
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O xidative stress plays a key role in premature aging of the cardiovascular system, and promotes an accelerated atherosclerosis characterized by a reduction of the endothelial cellular function including endothelial senescence, increased microparticle (MP) shedding, and a reduced nitric oxide (NO) formation. 1 MPs derived from the endothelium (EMPs) have recently emerged as a surrogate marker of endothelial injury and cardiovascular risk. 2 Moreover, MPs have been shown to be potent cellular effectors promoting oxidative stress, inflammation, and apoptosis, and they are possibly also actors of plaque growth and thrombogenicity. 3 Detected at high concentrations within the occluded coronary artery in patients with ST-segment-elevation myocardial infarction 4 and in patients with sudden cardiac death, 5 their intracoronary levels were demonstrated to be potent markers of impaired myocardial perfusion following percutaneous coronary intervention. 6 Beyond their role in the no-reflow phenomenon, 7 MPs exposing tissue factor (TF) are also thought to contribute to plaque thrombogenicity, 8 and to alter vascular function through enhanced oxidative stress, cytokines release, and endothelial intercellular adhesion molecule-1-dependent monocyte adhesion. 3 Recent findings have highlighted the potential role of angiotensin II (Ang II) in the generation of MPs both in vivo and in vitro. Ang II-induced hypertension was associated with elevated circulating levels of EMPs in ApoE -/-mice, and treatment of mouse aortic endothelial cells (ECs) with Ang II caused the release of EMPs via activation of AT1 receptors (AT1Rs). 9 In addition, because MPs released from low-passage ECs induced premature senescence and oxidative stress in cultured mouse aortic ECs, they might act as mediators of early endothelial dysfunction. 8, 10 The possibility that the prosenescent potential of EMPs is dependent on the health status of the originating ECs remains poorly studied.
Therefore, the present study examined whether the induction of endothelial senescence, as observed early at atheroprone vascular sites such as arterial bifurcations, 11, 12 is accompanied by a gradual shedding of MPs conveying deleterious messages toward the endothelial function. In addition, the potential of MPs isolated from the plasma of patients with acute coronary syndrome (ACS-MPs) to induce premature endothelial dysfunction typified by the induction of senescence and thrombogenicity was evaluated under both low and high shear stress conditions, and the role of the EMPs clarified. Moreover, because Ang II via NADPH oxidase-derived oxidative stress is a potent inducer of premature endothelial senescence and ECs express both angiotensinconverting enzyme (ACE) and AT1R, 10, 13 the potential role of the local Ang II/AT1R/NADPH oxidase system in the noxious impact of both senescent EC-derived MPs and ACS-MPs on premature endothelial dysfunction was determined.
METHODS
An expanded Methods is available in the online-only Data Supplement.
Patients
The Institutional Review Board approved all studies, and all participants gave informed consent. Thirty patients with ST-segment-elevation myocardial infarction or without ST-segment-elevation myocardial infarction treated by primary percutaneous coronary intervention within 24 hours of onset of symptoms were enrolled from the University Hospital Center of Strasbourg, France. The inclusion criteria were as follows: (1) chest pain, (2) ST changes on ECG indicating ischemia (ST-segment depression or elevation [≥2 mm] in at least 2 contiguous leads or T-wave inversion), and (3) positive biomarker level indicating myocardial necrosis (troponin I >0.04 ng/mL). Patients with a history of chronic inflammatory disorders or atrial fibrillation were excluded. Four healthy volunteers without cardiovascular risk factors were enrolled for comparison purposes.
All patients were treated by coronary angioplasty and stenting under appropriate antiplatelet and anticoagulant treatment. Peripheral blood samples drawn by vein puncture into evacuated collection tubes containing 129 mmol/L sodium citrate were processed within 30 minutes. Platelet-poor plasma containing circulating MPs was obtained by double centrifugation and thereafter immediately frozen and stored at -80°C according to the recommendation of the International Society of Thrombosis and Haemostasis.
14 For ex vivo experiments,
Clinical Perspective
What Is New?
• Endothelial-derived microparticles (MPs) from senescent coronary artery endothelial cells and from patients with acute coronary syndrome induced premature endothelial dysfunction, oxidative stress, senescence, and thrombogenicity through activation of AT1 receptors subsequent to the activation of the local angiotensin system. • Thrombogenicity of senescent endothelial cells was characterized by procoagulant MP release, enhanced tissue factor expression and activity, and increased platelet aggregation.
• Prosenescent effect of circulating MPs from patients with acute coronary syndrome was induced selectively under atheroprone low shear stress conditions.
What Are the Clinical Implications?
• During acute coronary syndrome, targeting endothelial cell-derived MPs shedding and their prosenescent and thrombogenic activities through AT1 receptor blockade may be of interest to delay premature endothelial aging.
platelet-poor plasma was thawed, subjected to 13 000g centrifugation for 90 minutes, and washed; recovered MPs were concentrated in Hank balanced salt solution before addition to cell culture medium. Procoagulant MP concentration was measured by prothrombinase assay and referred to as phosphatidylserine equivalents (PhtdSer eq). 15 Atherosclerotic plaques were retrieved from 8 patients undergoing surgical carotid endarterectomy, and internal mammary arteries were retrieved from 8 patients undergoing coronary artery bypass grafting. MPs were harvested after 90 minutes incubation in culture medium (Dulbecco modified Eagle medium, see online-only Data Supplement Methods).
Cell Culture and Biological Responses
Pig hearts were collected from the local slaughterhouse (COPVIAL) and ECs were isolated from the left circumflex coronary artery as described previously. 16 At regular intervals, ECs were sequentially passaged from P1 to P4 by splitting at a ratio of 1:3 using trypsin (Gibco-BRL). Premature EC senescence was induced either with H 2 O 2 (100 µmol/L), Ang II (10 µmol/L), or MPs (10 nmol/L PhtdSer eq) for 48 hours. In some experiments, ECs were exposed to a pharmacological modulator for at least 30 minutes before addition of MPs.
Senescence-associated β-galactosidase (SA-β-gal) activity was measured by flow cytometry using C 12 FDG, levels of protein expression by Western blot analysis, TF activity by spectrophotometry using CS11, oxidative stress by flow cytometry using dihydroethidium, and platelet aggregation using an aggregometer.
Statistical Analysis
All data were analyzed using R software (version 3.3.1 for Windows, The R Foundation for Statistical Computing). 17 All data are expressed as mean±standard error of the mean for n different experiments. Normality was analyzed using the Shapiro-Wilk test by clustering all the data of the experiment. When normality could not be rejected, 1-way analysis of variance was used followed by the Tukey post hoc test for multiple comparisons. When normality was rejected, Kruskal-Wallis nonparametric test followed by the Conover post hoc test were applied using the PMCMR package for R. 18 Group differences were considered statistically significant at P<0.05.
RESULTS
Replicative Passaging of ECs Progressively Increases Senescence and Shedding of Prosenescent MPs
Replicative passaging of ECs induced a progressive increase in the number of cells with SA-β-gal activity associated with the shedding of MPs without affecting the low level of apoptosis ( Figure 1A and 1B, online-only Data Supplement Figure I ). Cell cycle analysis by flow cytometry confirmed a higher proportion of ECs with cell cycle arrest in P3 cells than in P1 cells (online-only Data Supplement Figure II) .
Washed MPs harvested from the supernatant of either P1 or P3 ECs were added to young P1 ECs for 48 hours at the concentration of 10 nmol/L PhtSer eq previously reported in the plasma of ACS patients. 19 MPs from P3 senescent ECs (P3-MPs) but not from P1 ECs (P1-MPs) markedly increased SA-β-gal activity in target P1 ECs, and this effect was associated with ≈2-fold increased shedding of MPs ( Figure 1C and 1D ). P3-MPs also reduced the number of proliferating P1 ECs as evidenced by cell cycle analysis without affecting the level of apoptosis, suggesting a specific prosenescent effect (online-only Data Supplement Figures I and II) . The specificity of action of P3-MPs was also indicated by the fact that conditioned medium depleted of P3-MPs following extensive centrifugation did not induce premature senescence (online-only Data Supplement Figure III) .
The interaction of P3-MPs with target P1 ECs was assessed by using the fluorescent lipid probe PKH26. The capture of fluorescent MPs was observed in ≈82% of ECs by flow cytometry and fluorescent microscopy at 8 hours and thereafter remained stable for at least 24 hours ( Figure 1E and 1F).
P3-MPs induced the upregulation of p53, a key regulator in cellular senescence, and of p21 and p16, key cyclin-dependent kinase inhibitors, in P1 ECs. Similar responses were also observed in P1 ECs in response to H 2 O 2 , a strong inducer of premature endothelial senescence, 10 and in P3 untreated senescent ECs (Figure 1G through 1I).
MPs From Senescent ECs Induce an Increased Pro-Oxidant Response in Young ECs
Because reactive oxygen species (ROS) are strong inducers of senescence, 13, 20 experiments were performed to determine whether oxidative stress is involved in P3-MP-induced premature senescence using dihydroethidium. Indeed, P3-MPs like H 2 O 2 , but not P1-MPs, increased the level of ethidium fluorescence in P1 ECs (Figure 2A ). The source of ROS was characterized using inhibitors of major vascular sources of ROS including NADPH oxidase (VAS-2870), cyclooxygenases (COXs, indomethacin), cytochrome P450 (sulfaphenazol), and the mitochondrial respiration complex (myxothiazol+KCN+rotenone). VAS-2870, indomethacin, and the mitochondrial respiration complex inhibitors blunted the P3-MP-induced formation of ROS whereas sulfaphenazol had only minor effects ( Figure 2B ). These findings suggest that NADPH oxidase, COXs, and the mitochondrial respiration complex contribute to the P3-MP-induced oxidative stress. In addition, Western blot analysis indicated that P3-MPs upregulated p22 phox and p47 phox subunits of NADPH oxidase and COX-2, but not COX-1, in P1 ECs ( Figure 2C , 2D, 2F, and 2G). P3-MPs also upregulated the expression of p66
Shc , a redox-sen- ECs were subjected to serial passages from P1 to P4 before assessment of senescence by SA-β-gal activity using C12FDG (A), and the shedding of MPs in the supernatant using the prothrombinase assay (B). C and D, Young ECs at P1 were incubated for 48 hours with either H 2 O 2 (100 µmol/L), or MPs (10 nmol/L PhtdSer eq) isolated from the supernatant of either P1 ECs (Continued ) sor protein that induces ROS formation through NADPH oxidase activation 21 in P1 ECs ( Figure 2E ).
MPs From Senescent ECs Reduce the Endothelial Nitric Oxide Synthase-Derived NO Pathway in Young ECs
Because endothelial senescence is characterized by endothelial dysfunction and a reduced formation of NO, 22, 23 the effect of P3-MPs on the ability of ECs to inhibit platelet aggregation was assessed. Platelet aggregation was abolished by 10 5 P1 ECs in comparison with only ≈45% and 7% inhibition by senescent P3 and P3-MP-treated P1 ECs, respectively, suggesting a blunted formation of NO ( Figure 3A through 3C). Senescent P3 and P3-MP-treated P1 ECs exhibited also a 61.0±4.7% and 35.8±4.9% downregulation of the endothelial nitric oxide synthase (eNOS) protein expression level in comparison with P1 ECs, respectively ( Figure 3D ).
In addition, senescence shifted the endothelial phenotype to a procoagulant status in P3 ECs and in P3-MPtreated P1 ECs as evidenced by the upregulation of TF expression and activity ( Figure 3E and 3F ). An increased TF expression was also observed in P1 ECs in response to H 2 O 2 ( Figure 3E ).
The Local Angiotensin System Mediates the P3-MP-Induced Premature Senescence
Because ECs express ACE, and Ang II is a strong inducer of endothelial senescence and MP formation through enhanced oxidative stress in cultured murine aortic ECs, 13 the role of Ang II in P3-MP-induced ECs senescence was determined. As shown in Figure 4A , Ang II induced endothelial senescence to the same extent as that induced by P3-MPs in P1 ECs. The P3-MP-induced senescence was abolished in the presence of losartan, an AT1R antagonist, indicating a key role of the local Ang II system ( Figure 4A ). In addition, senescent P3 ECs and P1 ECs exposed to either P3-MPs or H 2 O 2 had an increased expression of ACE and AT1R in comparison with P1 ECs ( Figure 4B and 4C).
Because activation of the redox-sensitive mitogenactivated protein kinase (MAPK) p38 has been involved in the signaling pathway leading to senescence 24 and the shedding of procoagulant EMPs in response to tumor necrosis factor-α, 25 experiments were performed to determine the role of redox-sensitive kinases in H 2 O 2 -induced premature ECs senescence. As shown in Figure 4D , H 2 O 2 -induced senescence in P1 ECs was significantly inhibited by a selective inhibitor of either p38 MAPK (SB203580), c-jun N-terminal kinase (JNK, SP600125) and reduced by ≈31.7±7.1% by an inhibitor of extracellular signalregulated kinases (ERK1/2, PD98059), which, however, did not reach statistical significance ( Figure 4D ). These data indicate that several redox-sensitive kinases including p38 MAPK and JNK contribute to the induction of premature endothelial senescence in response to oxidative stress.
Circulating MPs From ACS Patients Induce Premature Endothelial Senescence Associated With a Characteristic Prothrombotic and Oxidative Pattern
To underscore the clinical relevance of the present observations, the biological effect of ACS-MPs was investigated. Clinical characteristics of the ACS patients are provided in Table. Most of the detrimental effects of P3-MPs on P1 ECs were also observed in response to ACSMPs applied at identical final concentration (10 nmol/L PhtdSer eq). ACS-MPs induced (1) a 2-to 4-fold increase of SA-β-gal activity in P1 ECs, (2) early oxidative stress, (3) upregulation of p16 and p21 expression, (4) A through C, NO release by ECs was assessed indirectly through their ability to inhibit platelet aggregation. P1 or P3 ECs were cultured on Cytodex 3 beads. Washed human platelet suspensions (450 µL) were pretreated for 2 minutes with beads harboring either untreated P1 ECs (A), P3-MP-treated P1 ECs (48-hour treatment with 10 nmol/L PhtdSer eq, B), or P3 ECs (C) before induction of submaximal platelet aggregation with U46619 (arrows). Representative aggregation traces (upper panels) and cumulative data (lower panels). D through F, P1 ECs were incubated with either H 2 O 2 (100 µmol/L) or P3-MPs (10 nmol/L PhtdSer eq) for 48 hours before determination of the expression level of eNOS (D) and TF (E), and TF activity measured by Tenase assay (F). Representative immunoblots (upper panels) and densitometric analysis (lower panels). Data are expressed as mean±SEM of experiments performed on 3 different cell cultures. * P<0.05 versus respective P1 cells (CTL). EC, endothelial cell; eNOS, endothelial nitric oxide synthase; MP, microparticle; NO, nitric oxide; PhtdSer eq, phosphatidylserine equivalents; SEM, standard error of the mean; and TF, tissue factor. ACS-MP-induced ECs senescence, whereas a nonsignificant reduction of 32.0±12.8% was observed with the p38 MAPK inhibitor ( Figure 6E ). Altogether, these findings suggest that ACS-MPs induce EC senescence through an early activation of the MAPK and the PI3-kinase/Akt pathways.
The Local Angiotensin System Mediates the ACS-MP-Induced Premature Endothelial Senescence via the NADPH Oxidase-Dependent Activation of MAPKs
Because the P3-MP-induced premature endothelial senescence is critically dependent on the local angiotensin system, experiments were performed to determine whether Ang II mediates the ACS-MP-induced EC senescence. Losartan abolished the ACS-MP-induced premature endothelial senescence, and both losartan and VAS-2870 prevented the ACS-MP-induced phosphorylation of p38 MAPK and pERK1/2 in P1 ECs (Figure 7A through 7C) . Similarly, perindoprilat, an ACE inhibitor, abolished the ACS-MP-induced phosphorylation of p38 MAPK, whereas that of ERK1/2 was reduced by 54.2±20.6%, but this effect did not reach statistical significance ( Figure 7B and 7C) . In addition, ACS-MPs increased the expression level of ACE and AT1R in P1 ECs ( Figure 7D and 7E) . Moreover, with the use of a functional assay, ACE activity was detected on the surface of ACS-MPs, which was abolished by Captopril, an ACE inhibitor ( Figure 7F ). 
Relationship Between ACS-MP-Induced Senescence and Shear Stress
Because shear stress is a main determinant of ECs survival, MP release, and senescence, the impact on ACSMPs on endothelial senescence was assessed at low (3 dynes/cm 2 ) and high (30 dynes/cm 2 ) levels of shear stress. After exposure of ECs at low shear stress for 4 to 6 hours, ACS-MPs (10 nmol/L PhtdSer eq) decreased nonsignificantly eNOS protein level by 41.7±16.0% (P<0.10) and increased significantly the expression of both p53 by 62.1±26.4% and p16 by 93.9±44.6% after a 24-hour incubation period ( Figure 8A through 8C) . In contrast, ACS-MPs did affect neither the increased level of eNOS nor the low expression level of p53 and p16 in ECs exposed to high shear stress ( Figure 8A through  8C) . To emphasize the clinical link between senescence and MPs in vascular tissues exposed to different flow conditions, senescence markers and MP content were determined in human carotid atherosclerotic plaques and internal mammary artery segments, which are exposed to low and oscillatory shear stress and high levels of shear stress, respectively. A high expression level of p53 and p16 was observed in most samples of carotid artery plaques, whereas only a low expression level was observed in the different mammary artery segments (Figure 8D and 8E) . Likewise, pronounced MP release was observed from atherosclerotic plaques in comparison with mammary artery segments ( Figure 8F ). To confirm the role of EMPs in the induction of senescence, ACSMPs were depleted of EMPs using beads coated with antibodies directed against CD31 and CD105 (endothelial identity markers) and platelet-derived MPs using beads Figure 5 . Circulating MPs from patients with ACS induce senescence and oxidative stress in P1 ECs.
MPs were isolated from blood of ACS patients or from healthy volunteers, washed, and concentrated. P1 ECs were treated with MPs (10 nmol/L PhtdSer eq) from an individual ACS patient (A, C through H) or a healthy volunteer (B) for 48 hours before determination of SA-β-gal activity (A and B) , the level of oxidative stress (C), and a target protein expression level (D through H). Representative immunoblots (upper panels) and densitometric analysis (lower panels). Data are expressed as mean±SEM of experiments performed on 3 different cell cultures, with the exception of B, C, F, and H (n=2). * P<0.05 versus control (CTL). ACS indicates acute coronary syndrome; EC, endothelial cell; MP, microparticle; PhtdSer eq, phosphatidylserine equivalents; SA-β-gal, senescence-associated β-galactosidase; and SEM, standard error of the mean. coated with an anti-GPIb antibody before treatment of P1 ECs. The immunodepletion findings indicate that a 57.8% removal of platelet-derived GPIb + -MPs led to a 24.7% reduction in the prosenescent effect of ACS-MPs, which, however, did not reach statistical significance ( Figure 8G and online-only Data Supplement Table IA ). In contrast, the total removal of CD31 + -MPs and CD105 + -MPs led to a significant 39.4% reduction in ACS-MP-induced endothelial senescence ( Figure 8G and online-only Data Supplement Table IA ). Moreover following removal of both endothelial and platelet-derived MPs, ACS-MPs did not induce a prosenescent endothelial response ( Figure 8G and online-only Data Supplement Table IB ). In addition, MPs generated ex vivo from human washed platelets and from lymphocyte and monocyte lineages did not induce premature senescence (online-only Data Supplement Figure IV) . Altogether, these findings indicate that circulating EMPs and platelet-derived MPs mediate ACS-MP-induced premature endothelial senescence.
DISCUSSION
The present findings indicate that EMPs derived from aging porcine coronary artery ECs or from ACS patients induce premature endothelial senescence and thrombogenicity that are dependent on Ang II-induced activation of AT1 receptors. Furthermore, the stimulatory pathway leads to an early NADPH oxidase-dependent oxidative stress, which, in turn, triggers both the MAPK pathway and the PI3-kinase/Akt pathway to ultimately induce senescence. Both types of EMP-induced premature senescence resulted in severe endothelial dysfunc- Figure 7 . The local angiotensin system mediates the circulating ACS-MP-induced redox-sensitive MAPK-mediated premature EC senescence.
A, P1 ECs were incubated with an AT1R antagonist (LOS, losartan, 30 µmol/L) for 30 minutes before the addition of ACS-MPs (10 nmol/L PhtdSer eq, ACS12-17) for 48 hours and the subsequent determination of SA-β-gal activity. B and C, P1 ECs were incubated either with losartan (LOS, 30 µmol/L), an ACE inhibitor (PER, perindoprilat, 0.1 µmol/L) or a NADPH oxidase inhibitor (VAS, VAS-2870, 5 µmol/L) for 30 minutes before addition of circulating ACS-MPs (10 nmol/L PhtdSer eq, ACS12-17) for 2 hours, and the subsequent determination of the phosphorylation level of p38 MAPK (B) and ERK1/2 (C). D and E, P1 ECs were incubated with circulating ACS-MPs (10 nmol/L PhtdSer eq, ACS 12-17) for 48 hours before the determination of the expression level of ACE (D) and AT1R (E). Representative immunoblots (upper panels) and densitometric analysis (lower panels). F, Circulating ACS-MP-associated ACE activity was assessed in the absence or presence of a selective ACE inhibitor (CAP, captopril, 100 µmol/L). Data are expressed as mean±SEM of experiments performed on 3 different cell cultures except for D, E, and F (n=2). *P<0.05 versus control (CTL).
# P<0.05 versus ACS-MPs. ACE indicates angiotensin-converting enzyme; ACS, acute coronary syndrome; AT1R, AT1 receptor; EC, endothelial cell; MAPK, mitogen-activated protein kinase; MP, microparticle; PhtdSer eq, phosphatidylserine equivalents; SA-β-gal, senescence-associated β-galactosidase; and SEM, standard error of the mean. Figure 8 . Level of senescence markers and MPs shedding in human vascular tissues exposed to different levels of shear stress, and role of endothelial-derived MPs in the ACS-MP-induced premature EC senescence.
A through C, P1 ECs were exposed to either no shear stress (Static), low (LSS, 3 dyne/cm 2 ), or high shear stress (HSS, 30 dyne/cm 2 ) for 4 to 6 hours before the addition of circulating ACS-MPs (10 nmol/L PhtdSer eq, ACS 18-22) for an additional 24 hours. Thereafter, the expression level of target proteins was assessed by Western blot analysis. Representative immunoblot (upper panels) and densitometric analysis (lower panels). Data are expressed as mean±SEM of experiments performed on 3 different cell cultures. *P<0.05 versus LSS.
# P<0.05 versus LSS ACS-MPs. D through F, Human vascular tissues exposed to laminar shear stress (internal mammary artery, IMA) or to low and oscillatory shear stress (carotid artery plaque, CAS) were collected from patients; thereafter, the expression level of p53 and p16 was determined by Western blot analysis. Representative immunoblots (D) and densitometric analysis (E). F, Total MPs released from IMA segments and coronary artery plaques (CAS) during a 90-minute incubation period (IMA, n=7; CAS, n=5). G, Effect of the removal of either (Continued ) tion characterized by eNOS downregulation, oxidative stress, upregulation of TF expression and activity, and generation of procoagulant MPs in ECs. The clinical relevance of these findings is supported by the fact that ACS-MP-induced premature endothelial senescence is observed only under atheroprone low shear stress, and that increased markers of senescence associated with pronounced MP shedding are observed in human atherosclerotic plaques. Furthermore, because the prosenescence endothelial response to MPs is associated with an overexpression of both ACE and AT1 receptors, the local angiotensin system possibly acts as an important amplifying system to accelerate the induction of endothelial dysfunction, senescence, and thrombogenicity, and, thereby, contributes to further worsen the function of the vascular system.
The potential role of senescence in endothelial dysfunction has lately attracted a lot of interest using cultured ECs and experimental models of cardiovascular diseases. Indeed, both premature EC senescence, as observed in response to Ang II or H 2 O 2, and replicative senescence are characterized by the association of oxidative stress with a pronounced downregulation of eNOS expression and the endothelial formation of NO. 16, 26 The present findings further extend these previous reports by showing that replicative senescence promotes, besides blunted NO formation, the appearance of a pronounced prothrombotic profile in senescent ECs as indicated by their reduced ability to prevent platelet aggregation, the upregulation TF protein expression and activity, and the enhanced shedding of procoagulant and prosenescent EMPs. The relationship of senescence to the induction of endothelial dysfunction in clinical settings remains poorly studied. Senescent ECs have been observed overlying atherosclerotic plaques in human coronary arteries and aortic arches and they appear to colocalize with features of the vulnerable plaque. 27 Moreover, during atherogenesis, early signs of endothelial senescence are detected predominantly at sites of disturbed flow and low shear stress characterized by an early endothelial dysfunction, suggesting that premature aging-related endothelial dysfunction may contribute to the focal nature of the pathology and possibly also to its initiation and progression. 12 Endothelial dysfunction related to aging and major cardiovascular diseases such as coronary artery diseases is associated with an enhanced shedding of MPs. 28, 29 Besides representing a surrogate marker of vascular dysfunction, MPs might also contribute to aggravate the function of the vascular system because circulating MPs from patients with myocardial infarction blunted endothelium-dependent relaxation in arterial rings. 9 Therefore, the possibility that senescent ECs are a pivotal source of deleterious MPs, which, in turn, contribute to promote premature endothelial dysfunction, was evaluated. With the use replicative senescence as an experimental model of coronary artery EC aging, the findings indicate that the progressive induction of endothelial senescence is paralleled by a gradual increased shedding of MPs and that senescent EC-derived MPs, in turn, have a greater ability to promote endothelial dysfunction typified by the induction of early senescence, thrombogenicity, and an impaired endothelial NO pathway. These observations are in good agreement with the progressive shedding of EMPs by senescent murine aortic ECs. 10 The potential clinical relevance of these observations is suggested by the fact that ACS-MPs induced premature endothelial senescence as effectively as Ang II and H 2 O 2 , whereas similar concentrations of MPs from healthy subjects were inactive. Moreover, because the prosenescent effect of ACS-MPs is no longer observed following their depletion of EMPs and platelet-derived MPs, it implies that both endothelial and platelet-derived MPs carry the prosenescent message. Altogether, these findings support the concept that senescent EC-derived MPs act as effective mediators propagating a prosenescent and prothrombotic message to neighboring ECs.
Previous studies have indicated that oxidative stress is a major inducer of EC senescence and that it mediates both premature endothelial senescence to Ang II, and also replicative endothelial senescence. 10, 16, 30 The present findings indicate that senescent EC-derived MPs and prosenescent ACS-MPs induce oxidative stress in young ECs, whereas MPs from nonsenescent ECs did not. In contrast, MPs released from cultured mouse aortic ECs increased the generation of superoxide anions and H 2 O 2 in young ECs, and this effect was unrelated to the senescent status of their originating ECs. 10 The mechanism accounting for such discrepancy in pro-oxidant effectiveness of MPs remains unclear, but may be related to the different vascular origin and species of ECs, and to differences in their intrinsic pro-or antioxidant systems or regulators of oxidative stress. Using several pharmacological tools, the senescent EC-derived MP-induced oxidative stress in young ECs has been shown to involve several major sources of ROS, including NADPH oxidase, COXs, and the mitochondrial respiratory chain. These pro-oxidant sources have also been involved in replicative senescence in coronary artery ECs, and both NADPH oxidase and the mitochondria in EMP-mediated oxidative stress in mouse aortic ECs. 10, 16 The fact that Ang II is a potent inducer of endothelial senescence and ECs express high levels of ACEpromoting Ang II formation 31 prompted us to test the hypothesis that the local angiotensin system may be involved in the prosenescent effect of EMPs. Indeed, losartan, an AT1R antagonist, abolished the senescent EC-derived MP-induced senescence in young ECs, and both senescent EC-derived MPs and ACS-MPs induced the upregulation of the expression level of ACE and AT1R in young ECs, possibly as a consequence of their prooxidant response. 32, 33 Altogether, these findings highlight a pivotal role of the local angiotensin system in the MP-mediated induction of premature endothelial senescence via activation of AT1R. Furthermore, because ACE activity is detected at the surface of ACS-MPs, it is likely that ACE carried by MPs and ACE present on target ECs contribute to activate in an effective manner the local angiotensin system leading ultimately to the induction of senescence. In addition, the characterization of the signal transduction pathway involved in ACS-MPinduced premature senescence using pharmacological inhibitors has indicated the involvement of PI3-kinase and MAPKs, including p38 MAPK and ERK1/2, and is associated with an early activation by phosphorylation of p38 MAPK, ERK1/2, JNK, and Akt. Moreover, because losartan and the NADPH oxidase inhibitor VAS-2780 prevented the ACS-MP-induced phosphorylation of p38 MAPK and ERK1/2, it implies that Ang II acts upstream via the activation of AT1R to induce NADPH oxidasemediated oxidative stress, which, in turn, triggers the phosphorylation of the redox-sensitive MAPKs and Akt to ultimately promote EC senescence. A pivotal role of p38 MAPK in EC senescence has also been suggested by the fact that an increased activation of p38 MAPK is observed in senescent human umbilical vein ECs following serum starvation, and that silencing p38 MAPKα decreased oxidative stress and increased NO formation in senescent ECs. 24 Shear stress, a mechanical force generated by blood flow on the vascular endothelium, has a pivotal role in vascular health, because high levels of laminar shear stress enhanced NO generation and eNOS expression, whereas low and oscillatory shear stress resulted in blunted NO formation, 34 induction of EMP release, 35 and endothelial senescence via a p53-dependent pathway. 12 In line with these previous findings, the prosenescent effects of ACS-MPs was observed only under low shear stress but not under atheroprotective high shear stress. In human vascular tissues, pronounced levels of senescence markers associated with a high MP content were observed in atherosclerotic plaques that are subjected to low and oscillatory shear stress in contrast to the low levels in mammary arteries exposed to laminar shear stress. Thus, at atheroprone vascular sites exposed to low shear stress, it is likely that MPs, together with a reduced generation of NO, contribute locally to the activation of senescent pathways. 12 Collectively, these findings reveal a feed-forward system during ACS whereby EMPs promote premature senescence of neighbor ECs and subsequent thrombogenicity.
CONCLUSION
The present findings indicate that EMPs from senescent coronary artery ECs and from ACS patients induced premature endothelial dysfunction, senescence, and thrombogenicity through Ang II/AT1R/NADPH oxidase-mediated activation of the MAPKs and the PI3-kinase pathways. They further suggest that targeting prosenescent EMPs shedding and their biological activity may be of interest to delay endothelial senescence and improve vascular health.
